Intrapartum Monitoring Devices Market size is anticipated to witness substantial gains from 2023 to 2032 driven by the surging popularity of safer and innovative ways of fetal evaluation during labor across the globe.
Recent advancements in the non-invasive monitoring technologies and the introduction of electronic fetal monitoring will complement the industry scenario. Preterm births, infections, birth defects, and intrapartum complications, such as birth asphyxia are among the leading causes of the majority of neonatal deaths. According to the World Health Organization (WHO), birth asphyxia accounts for 900,000 deaths every year and is a major contributor to early neonatal mortality. This increasing focus on preventing infant mortality in the early stages of birth will proliferate the demand for intrapartum procedures.
Based on product, the intrapartum monitoring devices market share from the electrode segment is anticipated to depict significant traction by 2032 owing to the growing use of internal fetal heart rate monitoring devices. It has been estimated that approximately 22% of all deliveries make use of fetal scalp electrodes (FSE) to monitor their health. The increasing incidences of neonatal morbidity across developed and developing countries are also expected to propel product adoption in the upcoming period.
With respect to end-user, the intrapartum monitoring devices market share from hospitals is expected to record substantial market development over 2032. The high preference of patients for hospitals can be attributed to the easy availability and accessibility to expert healthcare opinions and sophisticated technologies. The rapid influx of investments in the advancement of healthcare facilities will also strengthen the progression for intrapartum care in these healthcare settings.
From a regional frame of reference, the intrapartum monitoring devices market size in North America is poised to experience an exponential trajectory between 2023 and 2032. Multiple entities in the region are empowering the space of fetal monitoring software and devices. For instance, the American College of Obstetricians & Gynecologists recommends the use of intermittent fetal monitoring deployed with electronic monitors and other tools. Moreover, the presence of some of the leading manufacturers and the rapid stream of innovations and developments will contribute to the industry expansion in the region.
Some major companies in the intrapartum monitoring devices industry include Neoventa Medical, GE Healthcare, Mindchild Medical, Huntleigh Healthcare Limited, Cardinal Health, Rocket Medical, and others. These players are foraying into new collaborations, partnerships, and joint ventures to expand their business footprint globally and boost product innovation.